Stock Track | DIAGENS-B Soars 15.69% to Record High on Canton Fair Medical Model Debut and Strong Annual Report

Stock Track05-04 10:37

DIAGENS-B's stock soared 15.69% during the morning session, reaching a record high. The stock has shown significant momentum, with gains continuing from recent positive developments.

The surge follows the company's participation in the third phase of the Canton Fair, where it presented its self-developed iMedImage® medical imaging foundation model in the Smart Healthcare zone. The presentation attracted significant attention, with the company's booth crowded with buyers from regions including the Middle East, Southeast Asia, and Europe who showed strong interest in its technology and products.

Additionally, the company's 2025 annual report demonstrated strong performance with a 332% surge in technology licensing revenue, validating the feasibility of its large model commercial loop. DIAGENS-B maintains a dominant position with a 30.6% market share in a policy-driven essential sector, and the endorsement of its iMedImage® foundation model by leading institutions such as Tencent underscores its strategic value as a global AI medical infrastructure service provider.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1197313481?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-04 10:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1197313481","market":"hk","top_or_hot":-1,"title":"Stock Track | DIAGENS-B Soars 15.69% to Record High on Canton Fair Medical Model Debut and Strong Annual Report","media":"Stock Track","content":"<p>DIAGENS-B's stock soared 15.69% during the morning session, reaching a record high. The stock has shown significant momentum, with gains continuing from recent positive developments.</p><p>The surge follows the company's participation in the third phase of the Canton Fair, where it presented its self-developed iMedImage® medical imaging foundation model in the Smart Healthcare zone. The presentation attracted significant attention, with the company's booth crowded with buyers from regions including the Middle East, Southeast Asia, and Europe who showed strong interest in its technology and products.</p><p>Additionally, the company's 2025 annual report demonstrated strong performance with a 332% surge in technology licensing revenue, validating the feasibility of its large model commercial loop. DIAGENS-B maintains a dominant position with a 30.6% market share in a policy-driven essential sector, and the endorsement of its iMedImage® foundation model by leading institutions such as Tencent underscores its strategic value as a global AI medical infrastructure service provider.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | DIAGENS-B Soars 15.69% to Record High on Canton Fair Medical Model Debut and Strong Annual Report</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | DIAGENS-B Soars 15.69% to Record High on Canton Fair Medical Model Debut and Strong Annual Report\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-04 10:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>DIAGENS-B's stock soared 15.69% during the morning session, reaching a record high. The stock has shown significant momentum, with gains continuing from recent positive developments.</p><p>The surge follows the company's participation in the third phase of the Canton Fair, where it presented its self-developed iMedImage® medical imaging foundation model in the Smart Healthcare zone. The presentation attracted significant attention, with the company's booth crowded with buyers from regions including the Middle East, Southeast Asia, and Europe who showed strong interest in its technology and products.</p><p>Additionally, the company's 2025 annual report demonstrated strong performance with a 332% surge in technology licensing revenue, validating the feasibility of its large model commercial loop. DIAGENS-B maintains a dominant position with a 30.6% market share in a policy-driven essential sector, and the endorsement of its iMedImage® foundation model by leading institutions such as Tencent underscores its strategic value as a global AI medical infrastructure service provider.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02526","symbol_name":"德适-B","start_time":0,"source_url":"","article_id":"1197313481","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1197313481","pubTimestamp":1777862241,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"DIAGENS-B's stock soared 15.69% during the morning session, reaching a record high. The stock has shown significant momentum, with gains continuing from recent positive developments.The surge follows...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02526":"德适-B"},"translate_title":"股票赛道|广交会医疗模式首秀年报强势，DIAGENS-B大涨15.69%创历史新高","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02526":1},"content_text":"DIAGENS-B's stock soared 15.69% during the morning session, reaching a record high. The stock has shown significant momentum, with gains continuing from recent positive developments.The surge follows the company's participation in the third phase of the Canton Fair, where it presented its self-developed iMedImage® medical imaging foundation model in the Smart Healthcare zone. The presentation attracted significant attention, with the company's booth crowded with buyers from regions including the Middle East, Southeast Asia, and Europe who showed strong interest in its technology and products.Additionally, the company's 2025 annual report demonstrated strong performance with a 332% surge in technology licensing revenue, validating the feasibility of its large model commercial loop. DIAGENS-B maintains a dominant position with a 30.6% market share in a policy-driven essential sector, and the endorsement of its iMedImage® foundation model by leading institutions such as Tencent underscores its strategic value as a global AI medical infrastructure service provider.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1197313481","isCrawlerRequest":true}